Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Vor Biopharma Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- +10 vs. Q3 2022
- Shares held
- 60.2M
- +28.7M (+90.9%) vs. Q3 2022
- Total value
- $400.3M
- +$274.8M (+218.9%) vs. Q3 2022
- New holders
- 15
- 26 more added
- Sold out
- 5
- 6 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $893.0M |
| Q1 2026 | 80 | $716.9M |
| Q4 2025 | 55 | $332.0M |
| Q3 2025 | 37 | $183.4M |
| Q2 2025 | 35 | $91.9M |
| Q1 2025 | 46 | $43.2M |
| Q4 2024 | 52 | $67.6M |
| Q3 2024 | 54 | $33.5M |
| Q2 2024 | 71 | $54.5M |
| Q1 2024 | 69 | $139.7M |
| Q4 2023 | 60 | $134.1M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 71 | $187.8M |
| Q1 2023 | 60 | $325.7M |
| Q4 2022 | 58 | $400.3M |
| Q3 2022 | 48 | $125.5M |
| Q2 2022 | 49 | $154.8M |
| Q1 2022 | 58 | $187.9M |
| Q4 2021 | 61 | $362.0M |
| Q3 2021 | 55 | $481.2M |
| Q2 2021 | 51 | $571.2M |
| Q1 2021 | 49 | $1.31B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Vor Biopharma Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 116 | $771 | 0.00% | +6+5.5% | Added |
| Eagle Bay Advisors LLC | 150 | $998 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 250 | $1.66K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 838 | $6.00K | 0.00% | −734−46.7% | Reduced |
| Lazard Asset Management LLC | 1,614 | $10.0K | 0.00% | +1,614 | New |
| Nisa Investment Advisors, LLC | 3,900 | $26.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,942 | $26.2K | 0.00% | +2,243+132.0% | Added |
| UBS Group AG | 4,087 | $27.2K | 0.00% | +4,087 | New |
| Simplex Trading, LLC | 7,048 | $46.0K | 0.00% | +3,615+105.3% | Added |
| Chicago Partners Investment Group LLC | 10,911 | $62.8K | 0.00% | −3,638−25.0% | Reduced |
| Grimes & Company, Inc. | 10,856 | $72.2K | 0.00% | +10,856 | New |
| Charles Schwab Investment Management Inc | 10,875 | $72.3K | 0.00% | 00.0% | Unchanged |
| Bourgeon Capital Management LLC | 11,200 | $74.5K | 0.02% | +500+4.7% | Added |
| Bank of New York Mellon Corp | 12,245 | $81.4K | 0.00% | +12,245 | New |
| Boothbay Fund Management, LLC | 14,320 | $95.2K | 0.00% | +14,320 | New |
| Man Group plc | 16,953 | $112.7K | 0.00% | +16,953 | New |
| Morgan Stanley | 16,954 | $112.7K | 0.00% | +9,282+121.0% | Added |
| HRT Financial LP | 17,924 | $119.0K | 0.00% | +17,924 | New |
| Qube Research & Technologies Ltd | 19,834 | $131.9K | 0.00% | +5,000+33.7% | Added |
| Ergoteles LLC | 22,858 | $152.0K | 0.01% | −42,474−65.0% | Reduced |
| 683 Capital Management, LLC | 25,419 | $169.0K | 0.02% | +25,419 | New |
| Tower Research Capital LLC (TRC) | 25,881 | $172.0K | 0.01% | −20,779−44.5% | Reduced |
| Citadel Advisors LLC | 28,425 | $189.0K | 0.00% | +6,028+26.9% | Added |
| Marshall Wace, LLP | 30,487 | $202.7K | 0.00% | +30,487 | New |
| Northern Trust Corp | 36,775 | $244.6K | 0.00% | +13,653+59.0% | Added |
| Dimensional Fund Advisors LP | 41,474 | $276.0K | 0.00% | +8,529+25.9% | Added |
| Citigroup Inc | 41,538 | $276.2K | 0.00% | +41,092+9,213.5% | Added |
| LMR Partners LLP | 43,166 | $287.1K | 0.01% | +16,398+61.3% | Added |
| Renaissance Technologies LLC | 45,967 | $306.0K | 0.00% | +14,067+44.1% | Added |
| Susquehanna International Group, LLP | 47,897 | $318.5K | 0.00% | +47,897 | New |
| State Street Corp | 49,913 | $331.9K | 0.00% | +8,700+21.1% | Added |
| D. E. Shaw & Co., Inc. | 50,901 | $338.5K | 0.00% | +50,901 | New |
| Two Sigma Investments, LP | 54,403 | $361.8K | 0.00% | +39,797+272.5% | Added |
| Bollard Group LLC | 55,555 | $369.0K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 68,402 | $454.9K | 0.00% | +57,990+557.0% | Added |
| Trustees of Columbia University in the City of New York | 91,910 | $611.0K | 1.26% | +91,910 | New |
| AWM Investment Company, Inc. | 100,000 | $665.0K | 0.10% | +100,000 | New |
| Bridgeway Capital Management, LLC | 100,200 | $666.3K | 0.02% | +20,800+26.2% | Added |
| JPMorgan Chase & Co | 127,939 | $851.0K | 0.00% | −1,141−0.9% | Reduced |
| Walleye Capital LLC | 163,388 | $1.09M | 0.02% | +163,388 | New |
| Geode Capital Management, LLC | 166,765 | $1.11M | 0.00% | +31,167+23.0% | Added |
| BlackRock Inc. | 237,271 | $1.58M | 0.00% | −200,350−45.8% | Reduced |
| Ensign Peak Advisors, Inc | 299,500 | $1.99M | 0.00% | +90,000+43.0% | Added |
| Thrivent Financial for Lutherans | 306,811 | $2.04M | 0.01% | +4,399+1.5% | Added |
| OUP Management Co., LLC | 374,714 | $2.49M | 4.07% | 00.0% | Unchanged |
| Millennium Management LLC | 498,080 | $3.31M | 0.00% | +159,159+47.0% | Added |
| Sarissa Capital Management LP | 618,000 | $4.11M | 0.49% | 00.0% | Unchanged |
| Johnson & Johnson | 1,074,658 | $7.15M | 2.08% | 00.0% | Unchanged |
| Woodline Partners LP | 1,111,123 | $7.39M | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,191,330 | $7.92M | 0.00% | +534,188+81.3% | Added |
| Baker Bros. Advisors LP | 1,465,925 | $9.75M | 0.06% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 1,860,465 | $12.4M | 0.01% | +1,860,465 | New |
| Artal Group S.A. | 2,875,581 | $19.1M | 1.10% | +2,325,581+422.8% | Added |
| Laurion Capital Management LP | 3,182,889 | $21.2M | 0.59% | +2,325,581+271.3% | Added |
| 5AM Venture Management, LLC | 6,361,723 | $42.3M | 11.37% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 6,442,825 | $42.8M | 5.03% | +4,739,180+278.2% | Added |
| FMR LLC | 7,970,511 | $53.0M | 0.01% | +4,789,276+150.5% | Added |
| Ra Capital Management, L.P. | 22,748,880 | $151.3M | 3.07% | +11,627,907+104.6% | Added |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −255,162−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −111,808−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −19,062−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −356−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −109−100.0% | Sold out |